166 related articles for article (PubMed ID: 23519056)
1. Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.
Stovold R; Meredith SL; Bryant JL; Babur M; Williams KJ; Dean EJ; Dive C; Blackhall FH; White A
Br J Cancer; 2013 Apr; 108(8):1704-11. PubMed ID: 23519056
[TBL] [Abstract][Full Text] [Related]
2. Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.
Meredith SL; Bryant JL; Babur M; Riddell PW; Behrouzi R; Williams KJ; White A
PLoS One; 2016; 11(2):e0148404. PubMed ID: 26848743
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells.
Stovold R; Blackhall F; Meredith S; Hou J; Dive C; White A
Lung Cancer; 2012 Jun; 76(3):263-8. PubMed ID: 22177533
[TBL] [Abstract][Full Text] [Related]
4. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
5. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells.
Bevilacqua S; Gallo M; Franco R; Rossi A; De Luca A; Rocco G; Botti G; Gridelli C; Normanno N
Lung Cancer; 2009 Jul; 65(1):123-5. PubMed ID: 19261349
[TBL] [Abstract][Full Text] [Related]
6. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance serum N-POMC level in lung cancer patients].
Li LY; Luo WC; Lu ZL
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):291-4. PubMed ID: 7805561
[TBL] [Abstract][Full Text] [Related]
8. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
[TBL] [Abstract][Full Text] [Related]
9. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.
Pujol JL; Quantin X; Jacot W; Boher JM; Grenier J; Lamy PJ
Lung Cancer; 2003 Feb; 39(2):131-8. PubMed ID: 12581564
[TBL] [Abstract][Full Text] [Related]
11. High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR.
Perey L; Benhattar J; Peters R; Jaunin P; Leyvraz S
Br J Cancer; 2001 Nov; 85(11):1713-21. PubMed ID: 11742493
[TBL] [Abstract][Full Text] [Related]
12. Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts.
Rygaard K; Møller C; Bock E; Spang-Thomsen M
Br J Cancer; 1992 Apr; 65(4):573-7. PubMed ID: 1314069
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
Ma PC; Blaszkowsky L; Bharti A; Ladanyi A; Kraeft SK; Bruno A; Skarin AT; Chen LB; Salgia R
Anticancer Res; 2003; 23(1A):49-62. PubMed ID: 12683352
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer.
Watkins DN; Berman DM; Burkholder SG; Wang B; Beachy PA; Baylin SB
Nature; 2003 Mar; 422(6929):313-7. PubMed ID: 12629553
[TBL] [Abstract][Full Text] [Related]
16. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79.
Picon A; Leblond-Francillard M; Raffin-Sanson ML; Lenne F; Bertagna X; de Keyzer Y
J Mol Endocrinol; 1995 Oct; 15(2):187-94. PubMed ID: 8800643
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients.
Fukunaga Y; Bandoh S; Fujita J; Yang Y; Ueda Y; Hojo S; Dohmoto K; Tojo Y; Takahara J; Ishida T
Lung Cancer; 2002 Oct; 38(1):31-8. PubMed ID: 12367790
[TBL] [Abstract][Full Text] [Related]
19. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.
Oshita F; Sekiyama A; Suzuki R; Ikehara M; Yamada K; Saito H; Noda K; Miyagi Y
Oncol Rep; 2003; 10(1):105-8. PubMed ID: 12469153
[TBL] [Abstract][Full Text] [Related]
20. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
Marini AM; Fridman R; Kanemoto T; Martin GR; Guo Y; Passaniti A
J Natl Cancer Inst; 1992 Oct; 84(20):1582-7. PubMed ID: 1328660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
